Legal regulation of compulsory licensing of inventions and some aspects of enforcement in the field of pharmaceuticals
EDN: mxibtd
Abstract
The article considers the issues of legal regulation of compulsory licensing of inventions in international, regional and Russian legislation. Granting exclusive rights, the state, in order to optimise the functioning of the institution of patenting, simultaneously establishes both the limits of their exercise and the possibilities of their restriction. At the same time, Articles 1239, 1360 and 1362 of the Civil Code define the limitations of exclusive rights when the use of objects of patent rights is allowed without the consent of the right holders. The examples of the implementation of the mechanism of compulsory licensing show how, in emergency situations, the state exercises the power to restrict exclusive rights in cases where the use of objects of patent rights is allowed without the consent of the right holders. There is no reason to believe that compulsory licensing procedures provided for by Articles 1360 and 1362 of the Civil Code may lead to the destruction of the institution of patenting. As a result of the enforcement of the current rules, the monopoly position of patent holders has been eliminated and the population of the country as a whole, as well as certain groups of patients, are provided with vital essential medicines. At the same time, the interest of patent holders in intensifying negotiations on price reductions and resumption of supplies of medicines has increased.
About the Author
N. K. NikolaenkoRussian Federation
Natalia K. Nikolaenko, Cand. Sci. (Technical Sciences), Leading Researcher
Moscow, Berezhkovskaya emb., 30, bld. 1
References
1. Latynthev, A.V. (2024), “Application of civil law mechanisms of compulsory licensing in healthcare”, Patents and licenses, no 4, pp. 43–51.
2. Latynthev, A.V. (2023), “The difference between the legal nature of compulsory licensing and paid unlicensed use of patent protection objects”, Russian Law Journal, no 3, pp. 56–68.
3. Zavyalova, M. (2016) “Compulsory licensing as an exception mechanism in the pharmaceutical sector”, Remedium, no 12, pp. 6–14.
4. Vorozheviсh, А. S. ”Limits of the exercise and protection of the exclusive right of the patent holder”. Мoscow: Statut. 2018, 320 pp.
5. Gulbassarova, E. V. (2023) “Exceptions from the patent monopoly”, Journal of the Intellectual Property Court, no 41, pp. 23–32.
6. Malygina, A. N. (2021) “Institute of Compulsory Licensing in the Patent Law of the Russian Federation”, Journal of the Intellectual Property Court, no 31, pp. 56–687.
7. Bodenhausen, G. (1977), Parizhskaia konvencia ob intellectualnoy sobstvennosti: Kommentarii [Paris Convention for the Protection of Industrial Property: Commentary]. Translated by Tumanova N. L., in prof. Boguslavsky M. M. (ed.); Introductory article by Pitovranov E. P., Progress, Moscow, Russia.
8. Reference document on the exception regarding compulsory licensing SCP/30/3, May 21, 2019. Standing Committee on the Law of Patents, Thirtieth Session Geneva, June 24 to 27, 2019, available at: https://www.wipo.int/edocs/mdocs/scp/en/scp_30/scp_30_3-main1.pdf (Accessed 18 Nov 2024).
Review
For citations:
Nikolaenko N.K. Legal regulation of compulsory licensing of inventions and some aspects of enforcement in the field of pharmaceuticals. Bulletin of Federal institute of industrial property. 2024;3(4):374–383. (In Russ.) EDN: mxibtd
JATS XML










